INTRODUCTION
CCCTC-binding factor (CTCF) is a ubiquitous zinc-finger protein with a remarkable structural conservation among many animal species (reviewed in Phillips and Corces, 2009; Ohlsson et al., 2010) . CTCF regulates multiple genes and can act either as a repressor, by recruiting the Sin3a histone deacetylase and YB-1 transcription factor to target genes (Lutz et al., 2000; Chernukhin et al., 2000) , or as an activator by modulating longrange chromatin interactions between enhancers and promoters via intrachromosomal loops (Majumder et al., 2008; Hadjur et al., 2009) . These loops may be established either through the formation of CTCF homodimers bound to different genomic loci (Pant et al., 2004; Yusufzai et al., 2004) , or via cohesin complexes recruited to DNA in a CTCF-dependent manner (Parelho et al., 2008; Wendt et al., 2008) .
The function of CTCF has been investigated in detail during the control of differential gene expression within the Igf2/H19 imprinted locus (Bell and Felsenfeld, 2000; Hark et al., 2000) .
At this locus, the same enhancers are required for the activation of both genes, and hence only one gene can be expressed per parental allele (Bartolomei et al., 1993) . CTCF prevents de novo DNA methylation of the imprint control region and thus maintains the expression of the maternal H19 allele (Schoenherr et al., 2003; Fedoriw et al., 2004) . Furthermore, it was proposed that CTCF insulates the maternal Igf2 promoter from the influence of these enhancers by positioning Igf2 in a transcription inactive chromatin loop (Murrell et al., 2004) .
The original suggestion for CTCF displaying an insulating activity derived from an enhancer-blocking assay using a hypersensitive site located upstream the chicken b-globin gene in cultured cells. It was proposed that CTCF protects both b-globin genes from being silenced by the surrounding heterochromatin, and the neighboring olfactory receptors encoding genes from being activated by the nearby erythroid-specific enhancers (Bell et al., 1999) . However, this function was challenged after the deletion of Ctcf in erythroid cells did not lead to any ectopic activation of genes adjacent to the b-globin locus (Splinter et al., 2006) .
Except for few studies where CTCF binding sites were either deleted or mutated (Pant et al., 2004) , CTCF function was rarely approached in an organismal context. Analysis of mice carrying a Ctcf loss-of-function mutation in CD4 + T cells revealed that this protein regulates cell cycle progression of ab T cells in the thymus (Heath et al., 2008) . Furthermore, the inactivation or maternal depletion of Ctcf in murine oocytes leads to aberrant meiosis and mitosis followed by apoptosis at the four-cell stage (Fedoriw et al., 2004; Wan et al., 2008) , illustrating that this factor is essential for the survival of pre-implantation embryos. In humans, mutations in several genes encoding proteins involved in cohesion complex formation, such as Nipped-BLike, Smc1A, and Smc3, cause the Cornelia de Lange syndrome (CdLS; Dorsett, 2007) , whereas mutations in Esco2, a gene encoding another regulator of the cohesin complex, are responsible for the Roberts and SC phocomelia syndromes (Dorsett, 2007) . Both types of patients display slow growth, mental retardation, and limb defects (Dorsett, 2007) . CTCF-dependent changes in the expression of gene important for limb development, in particular of Hox genes, were proposed to cause the malformations observed in these patients (Dorsett, 2007; Nasmyth and Haering, 2009) .
Hox genes belonging to the HoxA and HoxD clusters indeed play critical roles during limb development (Zá ká ny and Duboule, 2007) . Although the inactivation of both Hoxd13 and Hoxa13 results in a lack of digits (Fromental-Ramain et al., 1996) , Hoxd11 and Hoxa11 compound mutants have severely truncated zeugopod (forearm, foreleg) elements (Davis et al., 1995) and the combined deletion of both the HoxA and HoxD clusters almost completely abrogated limb development (Kmita et al., 2005) . In developing limb buds, the Hoxd1 to Hoxd11 genes first follow a collinear and progressive activation in the presumptive domain of the future forearm . Although the molecular mechanisms responsible for this early phase of activation are as yet poorly understood, this early expression of Hox genes contributes to the activation of Shh within a small group of posterior mesenchymal cells, the zone of polarizing activity (ZPA; Riddle et al., 1993; . SHH, a key molecule for limb outgrowth and patterning (Riddle et al., 1993) is required for the maintenance of Fgf4 expression in the apical ectodermal ridge (AER; Laufer et al., 1994) . Regulatory interactions between SHH and FGF4 are reciprocal, thus leading to a positive feedback loop that promotes limb growth (Laufer et al., 1994; Zuniga et al., 1999) .
Along with Shh transcriptional activation, a second phase of Hoxd genes induction takes place in distal limb bud cells giving rise to the future autopod . This phase involves from Hoxd10 to Hoxd13 and is controlled by regulatory sequences located centromeric from the gene cluster (Spitz et al., 2003; Gonzalez et al., 2007; Montavon et al., 2008) . Lnp and Evx2, two genes located immediately centromeric to the HoxD cluster, are coexpressed with Hoxd genes in the autopod domain under the control of these potent enhancers. The analyses of spontaneous and genetically engineered mouse mutants have revealed the necessity for a tight regulation of these two partially overlapping groups of Hoxd genes, during these early and late phases, to achieve correct limb development. It is particularly critical to isolate the most posterior genes Hoxd12 and Hoxd13 from the early regulatory influence, to prevent serious deleterious gain of function effects (Peichel et al., 1997; Herault et al., 1997) .
Because genome-wide studies identified CTCF binding sites around and within the HoxD cluster in human cells (Kim et al., 2007; Barski et al., 2007) , this factor was proposed to function as an insulator to help organizing these regulatory domains (Kim et al., 2007) . The mapping of CTCF binding sites to boundary elements at the AbdominalB Hox gene locus in Drosophila (Holohan et al., 2007) strengthened this assumption. In this study, we report our investigations on the role of CTCF in Hoxd genes regulation during limb development, in physiological conditions. We mapped CTCF binding sites in limb mesenchyme for $10% of the mouse genome. Using a limb conditional mutation of Ctcf we identified presumptive target genes, suggesting a function for this protein during limb development. However, neither gene-expression profiling, nor transcriptome analysis indicates that CTCF either directly regulates Hoxd genes, or plays a role in insulating groups of genes from undesirable regulations.
RESULTS

Identification of CTCF Binding Sites in Limb Mesenchyme
We mapped CTCF binding sites in mouse limb mesenchyme using chromatin-immunoprecipitation, combined with DNA tiling arrays (ChIP-chip). Chromatin extracts were prepared from the distal part of embryonic limb buds, comprising both the future autopod and zeugopod domains, at day 10.75 of development (E10.75) ( Figure 1A ). Two biological replicates of ChIP material were hybridized to high density tiling arrays containing nonrepetitive sequences from chromosomes 2, X and Y, i.e., >10% of the mouse genome. The analysis of this data set for chromosomes 2 and X identified 908 enrichment peaks ( Figures 1B and 1C) , with peak score ranging from 1.5 to 24.7 (log 2 scale) and an average height and width of 4.3 and 300 bp, respectively. We validated these results by selecting 28 CTCF binding sites with low enrichment scores (1.5 < x < 2) and 20 sites with higher enrichment scores (x > 4.3) and performed quantitative polymerase chain reaction (PCR) analysis on two independent limb bud samples. Forty-six of forty-eight (95.8%) enrichment peaks were confirmed (see Figure S1 available online). The analysis of CTCF binding sites distribution relative to annotated genes (Kent et al., 2002) revealed that a large number of sites (64%) locates within intergenic regions ( Figure 1D ), 29% within genes and 7% near transcription start sites (TSS), defined here as within a one kb window from the TSS. The distribution of peaks within genes and intergenic regions was as expected by a random distribution, in contrast to the recruitments of CTCF to the TSS, which was 5.8-fold higher than expected (p value < 1 3 10
À10
, c 2 test). However, binding of CTCF to GC-rich sequences, which are overrepresented within promoters (CpG islands), may explain this bias in peaks' distribution. We analyzed the HoxD cluster in some details by focusing on a 2-mb large DNA interval. This highly syntenic region (Lee et al., 2006a) contains the HoxD cluster, the tightly associated Evx2 gene as well as four ubiquitously expressed genes (Atp5g3, Lnp, Mtx2, Hnrpa3) and two gene deserts on either sides with ranges of highly conserved noncoding DNA elements, including enhancer sequences responsible for transcriptional activation of the Hoxd genes during limb development (Spitz et al., 2003; Gonzalez et al., 2007) (Figure 1B ). We detected four CTCF binding sites $600 kb upstream the HoxD gene cluster and seven sites downstream the cluster ( Figure 1B ). We considered these as potential candidate sites to either insulate unrelated genes from limb-specific enhancers, or to mediate long-range chromosomal interactions to facilitate selective enhancerspromoters contacts involving specific subset of Hoxd genes in each limb domain. Accordingly, we found that seven of nine Hoxd genes were flanked by CTCF binding sites ( Figure 1C ), in particular immediately upstream the TSS of Evx2, Hoxd13, and Hoxd12, supporting a role for CTCF either in the transcriptional activation of these genes during digit development, or alternatively, in their exclusion from the action of forearm enhancers.
CTCF binding sites are generally common to different cell types (Kim et al., 2007; Barski et al., 2007) . We compared our data set with that reported for mouse ES cells (Chen et al., 2008) , where neither Hoxd genes nor Evx2 are expressed and 14 of our 17 CTCF binding sites were also detected in ES cells (Chen et al., 2008) . Furthermore, most of these peaks were also detected in various human cell lines (Kim et al., 2007; Barski et al., 2007) . However, the recruitment of CTCF to the promoter of Evx2 and upstream Hoxd12 was specific for limb cells ( Figure 1C ).
Limb Defects in Ctcf Conditional Mutant Mice
We assessed the physiological importance of these CTCF binding sites on the regulation of Hoxd genes by inactivating Ctcf in limb mesenchyme, using a conditional deletion allele (Heath et al., 2008) , combined with a Cre transgene under the control of the Prx1 promoter (Logan et al., 2002) . After recombination between loxP sites flanking the second and the last Ctcf exons, a lacZ reporter transgene becomes expressed under the control of the endogenous Ctcf promoter (Figure 2A ), 
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Functions of CTCF during Limb Development allowing for the visualization of mutant cells in the limbs. Using quantitative RT-PCR we determined that at least 90% of Ctcf RNA was depleted in mutant limbs, as compared to wild-type at E10.75 ( Figure 2B ). Western blot confirmed the severe reduction of CTCF protein levels in mutant limbs at the same developmental stage ( Figure 2C ). Furthermore, immunohistochemical analysis showed that CTCF was present in all cells in wild-type limbs ( Figure 2D ), whereas a vast majority of mesenchymal cells were CTCF negative in mutant limbs ( Figure 2E ). CTCF protein was expectedly scored in limb ectoderm (Figure 2E) , where the Prx1Cre transgene is inactive. Importantly, mutant and wild-type limbs were morphologically similar at this developmental stage.
To further quantify the amount of CTCF left in our mutant samples, we carried out an additional ChIP-chip experiment, using Ctcf mutant limbs. This data set revealed that 96% of CTCF binding events were lost in the mutant forelimbs at E10.75 (Figures 2F and 2G) . Analysis of the remaining 4% indicated that these peaks may represent false positives, as they partly overlap with low complexity or simple repeats regions. We thus concluded that the amount of CTCF in our mutant samples, if not totally abolished, is way below the physiological concentration. This massive decrease of CTCF lead to a dramatic truncation of the forelimbs, with a detectable size reduction as early as from E11.5 onward. Alcian blue staining of E14.0 embryos indicated that mutant forelimbs lacked all skeletal elements, including the scapula, humerus, radius, ulna, and digits (Figures 3A and 3B) . Although hindlimbs were less severely affected, due to the postponed and somewhat lower activity of the Prx1Cre transgene there (Logan et al., 2002) , mutant skeletal elements were still smaller than wildtype ( Figures 3C and 3D ). To assess whether such a drastic reduction in limb size was due to a deficit in cellular proliferation or, alternatively, to increased apoptosis, we compared cell proliferation and survival rates in mutant and wild-type embryos. BrdU incorporation was comparable in normal and mutant forelimbs at E11.5 ( Figures 3E-3H ), suggesting that proliferation was not critically affected. In contrast, apoptosis was strongly enhanced in mutant mesenchymal cells, when compared to wild-type at E11.5 ( Figures 3I-3L ), indicating that cell survival was strongly impaired in CTCF depleted cells. TUNEL positive cells were found on both anterior and posterior sides of the limb, indiscriminately, though with a higher occurrence within areas of active proliferation.
We further analyzed the molecular consequences of such a depletion of CTCF by genome-wide gene expression profiling using RNA extracted from wild-type and mutant distal limb buds at E10.75. We selected this early developmental stage to look for direct effects, rather than secondary consequences of size reduction, because only few apoptotic cells were scored in both wild-type and mutant distal limbs ( Figure S2 ). Pair-wise comparison analyses revealed 220 downregulated and 177 upregulated genes, as defined by using a >1.5-fold difference between mutant and wild-type limbs (Tables S1 and S2) .
As anticipated from the phenotype, multiple genes encoding apoptotic factors, mitochondrial proteins and enzymes responsible for the reduction of oxidative stress were misregulated in Ctcf mutant limbs (Table S3) . Furthermore, genes encoding factors involved in the G2/M transition checkpoint were overrepresented (11.7-fold) among deregulated genes, including Nibrin (Nbn). Yet the largest group of misregulated genes (44 of 397) was concerned with mitochondrial proteins. Although genes encoding subunits of the mitochondrial membrane respiratory chain NADH dehydrogenase complexes (Ndufab1, Ndufb7, Ndufaf3, and Ndufaf4), PAR glycohydrolase (Adprlh2), Frataxin (Fxn), glutamate oxaloacetate transaminase 2 (Got2), inorganic pyrophosphatase 2 (Ppa2), and Sirtuin 5 deacetylase (Sirt5) were downregulated, PUMA (Bbc3), which is responsible for the induction of cytochrome c release and apoptosis, was upregulated in Ctcf mutant limbs. ChIP-qPCR analyses demonstrated that CTCF was recruited to TSS of all tested downregulated mitochondrial genes and Bbc3 in mouse limb mesenchyme ( Figure 3M ).
Effect of CTCF on Transcriptional Regulation
We determined the overall consequences of CTCF depletion on the general transcriptional activity, i.e., including intergenic and intronic noncoding transcripts (ncRNAs), by comparing total RNAs from limb buds of both wild-type and mutant embryos, using tiling arrays covering chromosomes 2, X and Y. Comparative analyses of wild-type and mutant limbs transcript profiles revealed only few differentially expressed genes. Of these, 42 were downregulated, whereas 48 were upregulated by >1.5-fold (Tables S4 and Table S5 ), which represent $5% of all genes located on chromosomes 2 and X. The changes in transcripts abundance were arguably moderate, ranging from 1.5-to 2-fold. The results of RNA-chip assay were confirmed on 17 differentially expressed genes by quantitative RT-PCR carried out on three independent limb samples ( Figure S3 ). Fifty-one of fiftynine (86.5%) genes scored by using the gene expression arrays also appeared as differentially expressed when using RNA-chip on chromosomes 2 and X tiling arrays (Tables S1, S2 , S4, and S5).
In contrast, only 65% of those genes identified by RNA-chip were also scored when using the expression arrays. We looked at the correlation between the presence (binding) of CTCF and changes in gene expression. Nineteen genes (45%) detected as being downregulated after CTCF depletion had CTCF recruited to the transcription start site (TSS) in the wild-type condition, whereas nine (22%) had a CTCF binding site within 10 kb from the TSS and 14 (33%) had CTCF binding site further than 10 kb from the TSS (Figure 4A ), suggesting that a large fraction of those genes downregulated in Ctcf mutant may represent direct targets of CTCF. Likewise, 26% of all genes displaying CTCF bound to their TSS were downregulated in the mutant limbs, indicating that CTCF may exert part of its function by directly activating target promoters.
Among these downregulated genes were Jag1 and Grem1 ( Figures 4C and 4D ), two genes with important functions during limb development (Panman et al., 2006) . We detected CTCF recruitment to the TSS of Jag1 (Figure 4C ), as well as to enhancer sequences located within the Formin locus ( Figure 4D ), which are required for the activation of Grem1 in limb mesenchyme (Zuniga et al., 2004) . Moreover, several noncoding RNA genes, such as small nucleolar RNAs, were bound by CTCF and downregulated in Ctcf mutant limbs ( Figure 4E ; Table S1 ).
We also examined the effect of Ctcf loss of function on the transcription of imprinted loci. The transcriptional activity within the Gnas cluster (Williamson et al., 2004) was affected in mutant limbs, where we observed a reduced expression of two paternally expressed transcripts, Nespas (Nesp antisense) and Exon 1A. Accordingly, we identified two CTCF binding sites upstream of the respective promoters ( Figure 4F ). Changes in gene expression were also detected within the Dlk1/Gtl2 imprinted locus, as revealed by expression arrays (Table S6 ). All genes, including paternally expressed Dlk1 and maternally expressed Gtl2 and Rian, were downregulated >1.5-fold in Ctcf mutant limbs. At the Igf2/H19 locus, we detected a reduced expression of H19, yet without any visible gain of Igf2 expression (Table S6) .
In contrast, only two of the upregulated genes (4%) had CTCF bound near their transcription start sites, whereas 11 (23%) displayed CTCF binding within 10 kb from the TSS. Consequently, 35 upregulated genes (73%) were associated with a peak of CTCF occurring >10 kb away from the TSS (Figures 4B and 4G) . Genes induced >2-fold belong to this latter category, suggesting that their differential expression is a secondary effect, as supported by their specific expression in muscle (Dmd and Mtmr1) or ectodermal cells (Gpc3, Gpc4, Dlx2, Eda2r) . Noteworthy, with the exception of Eif2s2 and Phf6, all upregulated genes were either silent, or expressed at very low levels in wild-type limbs ( Figure 4G ), making it likely that the observed changes in expression are due to slight modification in the ratio between cells of mesenchymal and nonmesenchymal origin.
Using the chromosomes 2, X and Y tiling arrays, we identified a third class of genes with modified transcriptional activity in Ctcf mutant limbs, i.e., those where differential regulation was restricted to intronic sequences (Table S7 ; Figures 4H and 4I) . In all cases, intronic transcripts were downregulated in mutant limbs. Twenty-one of these genes (50%), which were not included in the 42 ''downregulated'' genes, displayed CTCF binding within the gene body, 13 (29.5%) of which with the binding event within the intron. This group of CTCF targets mostly contained genes encoding multiple isoforms and transcripts lost in the mutant configuration contained either exons used for alternative initiation, cassette exons or retained introns (Kent et al., 2002) . However, $1000 expressed genes located on chromosomes 2 and X did not show splicing defects in mutant limb cells, suggesting that CTCF does not play a generic role in intron excision. Instead, it may regulate the production of specific alternative transcript variants. In summary, CTCF was found to predominantly activate (or derepress) transcription of target genes during limb development. A large number of CTCF-associated genes were not differentially expressed between mutant and wild-type tissues, indicating that the recruitment of CTCF to these sites is not required for proper transcriptional regulation in limb mesenchyme.
Hoxd Genes Expression in Ctcf Mutant Limb
Genes located at the 5 0 extremity of the HoxD cluster, including Evx2 and from Hoxd13 until Hoxd10 were bound by CTCF and
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Functions of CTCF during Limb Development downregulated in mutant limbs ( Figure 5A ). In wild-type limb buds, 5
0 Hoxd genes are transcribed in the autopod (the future hand) with a strict graded quantitative regulation, Hoxd13 being expressed the strongest whereas Hoxd9 is barely detectable (Montavon et al., 2008) (Figure 5A ). Because Evx2 is positioned between Hoxd13 and the autopod specific enhancers, it also falls under the influence of these global enhancers and is thus concomitantly expressed in wild-type autopod (Spitz et al., 2003; Gonzalez et al., 2007; Montavon et al., 2008;  Figure 5A ).
In Ctcf mutant limbs, the transcription of Evx2 gene was significantly reduced (4.5-fold), whereas Hoxd13 transcription was moderately changed (2.4-fold reduction) and that of Hoxd10 virtually unchanged (1.2-fold reduction; Figure 5B ). In contrast, RNA levels of the more proximally expressed Hoxd genes, such as Hoxd9 and Hoxd8 were increased %3-fold in mutant limbs ( Figures 5A and 5B ). Whole mount in situ hybridization revealed that Hoxd13 was expressed in a slightly more restricted area of the posteriordistal part of the developing limb in mutants animals, when compared to wild-type at E10.75 ( Figures 5C and 5D ). Likewise, Hoxd10 was detected in almost all cells in wild-type limbs, whereas it appeared downregulated in the anterior part of the Ctcf mutant limbs ( Figures 5E  and 5F ). Altogether, the expression patterns of autopod-specific genes, such as Evx2 and Hoxd13 were qualitatively similar to wild-type at E11.5 ( Figures 5G-5J ). Hoxd10 transcripts were also found at similar levels in both the autopod and posterior zeugopod domains in mutant and wild-type limbs at E11.5 ( Figures 5K and 5L) . Therefore, during limb development, the activation of Hoxd genes by enhancers located on either sides of the gene cluster is largely independent from CTCF.
The ectopic (or elevated) expression of Hoxd9 was not observed in Ctcf mutant limbs, when compared to wild-type at E11.5 or E10.75 (Figures 5M and 5N ; Figures S4A and S4B) . Furthermore, we did not detect ectopic expression of Evx2, Hoxd13 or of any other Hoxd genes analyzed, in either the zeugopod (forearm) or stylopod (arm) domains, indicating that CTCF binding within the HoxD cluster is not necessary to insulate posterior Hoxd genes from the influence of the early limb enhancers.
Loss of Shh in Ctcf Depleted Limbs
The severe distal truncation of the limb, added to a decrease in the transcription of 5 0 Hoxd, Grem1, and Jag1 genes in mutant limbs, suggested that the function of Sonic hedgehog (Shh) had been affected. Accordingly, we scored a strong downregulation of Shh in mutant limbs ( Figures 6A and 6B ). The expression of Fgf4, a gene whose transcription in the apical ectodermal ridge (AER) serves as an indicator of Shh activity (Laufer et al., 1994) was also lost (Figures 6C and 6D ). In contrast, Fgf8 expression in the AER was identical between mutant and wild-type limbs ( Figures 6E and 6F) . Shh also regulates the expression of Grem1 in distal limb mesenchyme (Zuniga et al., 1999) , which in turn is required to establish the expression domain of Jag1 (Panman et al., 2006) . Consistently, the expression of both Grem1 and Jag1 was strongly decreased in Ctcf mutant limbs ( Figures 6G-6J ).
DISCUSSION
Genome-wide studies have identified >14,000 DNA sites occupied by CTCF in different human and murine cells (Kim et al., Figures S4C-S4F ). In Ctcf deficient limbs, the levels and the spatial distribution of transcripts remained similar to that in wild-type for all genes examined. Noteworthy, the most distal domain (autopod) was reduced in Ctcf mutant limbs when compared to wild-type at E11.5. Limb buds are oriented with anterior at the top. Scale bars represent 200 mm.
2007
; Barski et al., 2007; Chen et al., 2008) . However, the biological relevance of this binding was assessed in some details for a few genes only, leading to different suggestions regarding the function of this factor (Schoenherr et al., 2003; Fedoriw et al., 2004; Splinter et al., 2006; Heath et al., 2008; Majumder et al., 2008; Ribeiro de Almeida et al., 2009; Hadjur et al., 2009; Gomes and Espinosa, 2010) . We looked at the function of CTCF during early limb development in vivo, using a conditional allele of Ctcf in mutant mice, and our mapping of CTCF binding sites identified a majority of DNA fragments located within intergenic regions, far from gene promoters, in agreement with previous studies (Kim et al., 2007; Barski et al., 2007; Chen et al., 2008) . Such target sites were proposed to function as insulators, preventing the undesirable activation of genes by tissue specific enhancers located at their vicinity (Kim et al., 2007) .
This hypothesis naturally applied to gene members of the Hoxd cluster, because a clear partition must exist between expressed and nonexpressed neighboring genes to properly build and pattern our appendages (Zá ká ny and Duboule, 2007) . In addition, these complex regulations occur in a genomic region rich in CTCF binding sites and via long-range acting enhancer sequences. However, despite this paradigmatic situation for CTCF acting as an insulator protein, our data do not support this hypothesis and altogether show no evidence for such a function of CTCF, at least in developing limb mesenchyme.
Expression of Evx2 and 5
0 Hoxd genes, such as Hoxd13 and Hoxd12, was indeed still restricted to the distal part of the limb in Ctcf mutant fetuses, much like in wild-type limb buds. This result shows that CTCF is not required for blocking the activation of either Hoxd13, or Hoxd12 in the proximal limb domain (the future forearm) by the early limb enhancers located telomeric to the gene cluster, as suggested by both the presence of CTCF binding sites at the expected locations and the previous observation that these enhancers are capable to ectopically induce the expression of these two genes under experimental conditions (Zá ká ny et al., 2004; .
Likewise, Hoxd genes expressed in the future forearm region, such as Hoxd8 or Hoxd9, were not dramatically upregulated in most distal cells, after depletion of CTCF, and remained mostly silent in this domain. Therefore, the strict topographic dichotomy in Hoxd gene regulation, necessary for proper limb development, was not affected in Ctcf mutant appendages. The remaining low amount of CTCF can hardly account for this result. First, only 10% of cells with the floxed Ctcf allele still contained enough CTCF to be detected by immunohistochemistry and, consequently, any potential gain of function occurring in CTCF-negative cells should have been scored in our assay. Second, >10% of peaks remained in our mutant samples, when analyzed for CTCF binding events by ChIP.
Multiple CTCF binding sites were also detected at the three paralogous loci, i.e., within the HoxA, HoxB, and HoxC gene clusters (Kim et al., 2007; Barski et al., 2007; Chen et al., 2008) , as well as within the AbdominalB (AbdB) gene locus in Drosophila (Holohan et al., 2007) , which is the gene cognate of posterior (Hoxd13 to Hoxd9) Hox genes in mammals. Yet again, the expression patterns of both Hoxa13 and Hoxa11 remained mostly unchanged in Ctcf mutant limbs, when compared to wild-type ( Figures S4C-S4F) . Likewise, we did not detect any ectopic induction of either Hoxb or Hoxc genes in Ctcf mutant limb mesenchyme. This is similar to the case of Drosophila CTCF, which binds Fab-8, an insulator element required for the restricted expression of AbdB in the most posterior segments of Drosophila embryo (Moon et al., 2005; Holohan et al., 2007) . However, AbdB is not expressed ectopically in embryos lacking CTCF. Instead, CTCF is required for the maintenance of AbdB expression in its normal domain (Mohan et al., 2007) .
Furthermore, mutant limb cells did not overexpress any gene located nearby strongly expressed loci known or suspected to be under the control of remote limb enhancers, including Shh (Lettice et al., 2003) , Grem1 (Zuniga et al., 2004) , Bmp2 (Dathe et al., 2009) , Gli3 (Abbasi et al., 2010) , or the HoxA genes (Lehoczky and Innis, 2008) , supporting the conclusion that the precise partition between expressed and nonexpressed genes, often interspersed within one another at these various genomic loci, does not depend (at least solely) on the presence of the CTCF protein. The same conclusion was reached after looking at some loci on chromosomes 2 and X, where no ectopic expression was detected for genes flanking transcriptionally active loci and separated from them by a CTCF binding site(s). For instance, olfactory gene clusters remained transcriptionally silent in Ctcf mutant limbs, even though they flank genes highly expressed in limb cells.
Altogether, expression analyses of genes playing key roles during limb morphogenesis did not reveal any obvious developmental cause of the extreme truncation observed in Ctcf mutant forelimbs. Whereas Shh expression was strongly weakened, likely impacting on both Fgf4 and the absolute amount of Hoxd transcripts, the phenotype of Shh full loss-of-function in forelimbs is not as severe and hence this downregulation of Shh may only account for part of the effect. We thus conclude that this striking phenotype is caused by massive cell death, resulting from impairment in a basic cellular process(es), rather than by the misregulation of critical ''limb patterning'' genes, due to the depletion of CTCF.
In contrast, a clear effect was scored on the transcriptional activation and maintenance of those genes with a TSS bound by CTCF. Within this group, the number of downregulated transcription units was 9-fold higher than the upregulations. CTCF associates with RNA Pol II complexes (Chernukhin et al., 2007) and maintains the expression of imprinted genes by protecting their GC-rich promoters from de novo DNA methylation (Schoenherr et al., 2003; Fedoriw et al., 2004) . Accordingly, several imprinted genes, expressed either from the maternal or the paternal alleles, were downregulated in Ctcf mutant cells. It was also proposed that CTCF blocks the spreading of a silencing chromatin domain from the neighboring genes or intergenic regions into transcriptionally active loci that escape X chromosome inactivation . We did not detect any significant loss of expression for genes located on the X chromosome within regions escaping X-inactivation in female Ctcf mutant limbs.
The largest group of downregulated genes in Ctcf mutants limb was composed of nuclear genes encoding mitochondrial proteins. These genes are transcriptionally coregulated and the analyses of their core promoters revealed the presence of an ATGGCGG motif (Cunningham et al., 2007) , a sequence both known to recruit the transcription factor YY1, and part of the CTCF binding site (Kim et al., 2007; Barski et al., 2007) . Our data and genome-wide mapping of CTCF binding sites in human resting CD4 + T cells (Barski et al., 2007) show that all nuclear genes encoding mitochondrial proteins, which are downregulated in Ctcf deficient limb mesenchyme, have CTCF bound to their TSS. It is thus possible that CTCF controls cellular homeostasis by directly regulating the transcription of various mitochondrial genes. Multiple lines of evidence suggest that CTCF is essential for cell survival (Fedoriw et al., 2004; Wan et al., 2008) . Consistent with Gomes and Espinosa (2010) , we show that the proapoptotic gene Bbc3 (PUMA) is likely a direct target of CTCFmediated repression in limb mesenchyme. Gene expression analysis on chromosomes 2 and X revealed only two genes with CTCF bound at their TSS and upregulated in Ctcf mutant limbs, supporting the observation that only a few silent genes display CTCF on their TSS. In fact, the proportion, rather than absolute number, of genes with CTCF at their promoters, which were expressed in control limbs and downregulated in the mutant counterparts was comparable to the proportion of silent genes upregulated in the mutant situation, indicating that CTCF can likely function either as a transcriptional activator or repressor, depending on the recruitment of additional factors.
One-third of CTCF binding sites resides within introns (Kim et al., 2007 ; this study) and we identified genes showing a downregulation of intronic transcripts only, in CTCF depleted cells. It is thus possible that CTCF activates transcription from cryptic promoters within introns, leading to poorly abundant, noncoding transcripts. Alternatively, CTCF might affect the pre-mRNA splicing by controlling the rate of RNA polymerase II elongation or by recruiting chromatin-modifying enzymes (de la Mata et al., 2003; Luco et al., 2010) . The presence of various modifications on histone H3 has been recently associated with either the presence or the absence of alternative exons in mRNAs (Luco et al., 2010) and the correlation between CTCF binding and the tri-methylation of H3K4 at the promoters (Wang et al., 2008) suggests that CTCF could facilitate the positioning of this histone mark over alternatively spliced exons.
EXPERIMENTAL PROCEDURES Mouse Lines and Genotyping
The Ctcf loxP and Prx1Cre mouse lines were described previously (Heath et al., 2008; Logan et al., 2002) . 
ChIP-Chip
Limb buds were dissected from E10.75 mouse embryos, fixed in 1% formaldehyde for 15 min at room temperature, washed three times with cold phosphate buffer solution (PBS) and stored at À80 C. Pools of 16 limb buds were used for each ChIP-chip experiment. ChIP was performed according to (Lee et al., 2006b ) using 2 mg of anti-CTCF antibodies (A300-543A, Bethyl Laboratories) and EZview Red Protein G/A Affinity Gel (Sigma). Immunoprecipitated and whole cell extract DNA (input) were treated with RNaseA, proteinase K and purified by two rounds of extraction with phenol/chloroform/isoamyl alcohol. ChIP and input DNA were amplified using ligation-mediated PCR (Lee et al., 2006b) . PCR was limited to 15 cycles. ChIP (1.5 mg) and input DNA were fragmented and labeled using GeneChip WT Double-Stranded DNA Terminal Labeling Kit (Affymetrix) and hybridized to the Chromosome 2 and X tiling arrays (Affymetrix). The arrays are based on NCBI build 33 of the mouse genome (mm5) and contained >6.5 million perfect match oligonucleotide probes positioned every 35 bp mapping to the reverse strand Chromosome 2 and X. Two independent ChIP-chip experiments were performed.
Gene Expression Profiling
Limb buds were dissected from E10.75 mouse embryos and stored in RNAlater reagent (QIAGEN), for genotyping. For each replicate, RNA was isolated from pools of six limb buds either of wild-type or homozygous mutants, using RNeasy micro-kit (QIAGEN). cRNA was synthesized according to the manufacturer's instructions (Ambion) and hybridized to the GeneChip Mouse Genome 430 2.0 Arrays (Affymetrix), which interrogates $39,000 transcripts. Three independent RNA extractions, cDNA synthesis and array hybridizations were performed. The expression arrays data were normalized and scaled to signal intensity of 100 using GCOS 1.2 software (Affymetrix). Expression levels were analyzed using GeneSpring software (Silicon Genetics, Redwood City, CA) and MATLAB 2009 (The MathWorks, Natick, MA). A 77% cutoff in consistency of change (at least seven of nine comparisons were either increased or decreased) was applied. Only genes that satisfied the pair-wise comparison test and displayed R1.5-fold change in expression were considered for further analysis. Gene ontology analysis was performed using the database for annotation, visualization and integrated discovery (DAVID) (Huang da et al., 2009 ).
Transcript Profiling Using Chromosome 2 and X Tiling Arrays Limb buds were dissected from E10.75 mouse embryos and stored in RNAlater reagent (QIAGEN), for genotyping. For each replicate, RNA was isolated from pools of 6 limb buds either of wild-type or homozygous mutants using RNeasy micro-kit (QIAGEN). rRNA was depleted using RiboMinus Human/Mouse Transcriptome Isolation Kit (Invitrogen). After cRNA amplification, single or double-stranded cDNA was generated using The GeneChip Whole Transcript Amplified Double-Stranded Target Assay kit (Affymetrix) according to manufacturer's instructions. cDNA was fragmented and labeled using GeneChip WT Double-Stranded DNA Terminal Labeling Kit (Affymetrix) and hybridized to oligonucleotide tiling arrays. The control genomic DNA samples were fragmented with DNase I. Three independent RNA extractions, cDNA synthesis and array hybridizations were performed.
Analysis of Tiling Array Data
Tiling arrays data were quantile normalized within cDNA/genomic DNA or ChIP/input replicate groups using R packages, STARR and Ringo (Zacher et al., 2010; Toedling et al., 2007) . The ratio of probe intensity between the experiment and the control groups were computed considering the median values over replicates. The ratios were smoothened by computing the running medians with a half window size set to 150 bp and a minimum of five probes per window. To identify enriched regions a minimum of three consecutive probes with a smoothed ratio exceeding a threshold have been considered. The threshold has been fixed by taking the 99th percentile of the estimated null distribution of the ratios. Only ChIP enriched regions with score log 2 R 1.5 and width R 150 bp were considered for further analysis. RNA-chip data were computed at the exon level, by averaging the normalized intensities of all probes falling within the exon. As a complement, array data were quantile normalized within cDNA/genomic DNA or ChIP/input replicate groups and scaled to medial feature intensity of 10 (transcriptome) or 500 (ChIP-chip) using TAS software (Affymetrix). For each genomic position, a data set was generated consisting of all probes mapping within a sliding window of 80 bp (transcriptome) or 250 bp (ChIP-chip). The averaged ratios were plotted along the genomic DNA sequence using Integrated Genome Browser (IGB) software (Affymetrix).
ChIP-Quantitative Real-Time PCR and Quantitative Reverse-Transcription PCR of mRNA Analyses To obtain material for homozygous mutants, each pair of limb buds was processed separately and pooled after genotyping. For qRT-PCR, around 150 ng of total RNA from wild-type and Ctcf mutant limbs was reverse transcribed using random primers (Invitrogen). Expression changes were then normalized to Rps9. PCR primers were designed using Primer Express 2.0 software (Applied Biosystems). ChIP, total genomic DNA (input), and cDNA were PCR amplified using SYBR green containing qPCR master mix kit (Eurogentec) with iCycler (Bio-Rad). A mean quantity was calculated from triplicate reactions for each sample. Primers used are listed in Tables S8-S10 .
Histological Techniques and In Situ Hybridization
Wild-type and mutant embryos (n R 5) were age-matched according to their somite numbers, fixed in 4% formaldehyde in PBS, and processed for paraffin wax embedding. Immunohistochemical analyses were performed on 5-mm paraffin sections using 1:500 anti-CTCF antibody (A300-543A Bethyl Laboratories) and Vectastain Elite ABC kit (Vector Laboratories) according to the manufacture's instructions. BrdU was detected using a 1:250 anti-BrdU antibody (Invitrogen), followed by 1:300 Cy5-conjugated goat anti-mouse secondary antibody (Invitrogen). Apoptotic cells were detected using a DeadEnd Colorimetric TUNEL System (Promega) according to manufacture's instructions. b-galactosidase staining of embryos was performed as described (Spitz et al., 2003) . Skeletons of E14.0 embryos were prepared and stained with Alcian blue 8GX. Whole-mount in situ hybridization was performed using digoxigenin-labeled (DIG) RNA probes (Roche) as described (Spitz et al., 2003) .
Western Blot
Limb buds were dissected from E10.75 mouse embryos and stored in PBS at À80 C for genotyping. Protein lysates was isolated from pools of six limb buds either of wild-type or homozygous mutants. CTCF protein was detected using a rabbit anti-CTCF antibody (A300-543A, Bethyl Laboratories) and mouse anti-tubulin (T5168 Sigma), with HRP-conjugated secondary antibodies (Sigma) and ECL detection reagents (Perkin-Elmer).
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